FRANKFURT (dpa-AFX) – After separating from its fertility clinics, Fresenius (Fresenius SECo) is also putting its rehabilitation facilities up for sale, according to a press report. As the “Frankfurter Allgemeine Zeitung” reported in advance on Friday, citing various sources from industry and banking circles, this involves around 60 rehabilitation homes and some retirement homes in five countries. The project should have a value of 600,000 to 800,000 euros. Fresenius and the major Swiss bank UBS, which was mandated for the project, declined to comment.
The heavily indebted Bad Homburg DAX group (DAX 40) is in the middle of restructuring. Fresenius boss Michael Sen had already announced the separation from a “handful” of companies in the spring. Since then, the Eugin Group, which focuses on reproductive medicine, and a clinic in Peru have been sold.
The rehabilitation division, which will now be in the shop window, belongs to the Fresenius subsidiary Vamed. The Austrian company was still in the red in the second quarter, so the business is being turned inside out. According to previous reports, there were also interested parties for Vamed’s project division in the summer.
As the FAZ further learned, Vamed’s rehabilitation centers are said to have recently generated around 50 million euros in earnings before taxes and interest (EBIT). The earnings before taxes, interest, depreciation and amortization (Ebitda), which is important for the purchase price valuation, do not differ significantly./tav/stw/jha/
Selected leverage products on Fresenius
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Fresenius
The leverage must be between 2 and 20
Advertising